Gastrointestinal (GI): NSAIDs that block COX-1 activity have correlations with GI troubles due to the inhibition of the synthesis of gastroprotective brokers like PGE2 as well as other prostaglandins. This inhibition causes reduced mucin production by gastric epithelial cells, much less bicarbonate secretion, and fewer epithelial mobile turnover, amongst other https://diclofenacsodium79470.blogocial.com/rumored-buzz-on-diclofenac-sodium-65849553